La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

R. F. Peppard And NotRadiodiagnostic

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
001000 R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada]Cerebral glucose metabolism in Parkinson's disease with and without dementia
001051 B. J. Snow ; R. F. Peppard ; M. Guttman ; J. Okada ; W. Martin ; J. Steele ; A. Eisen ; G. Carr ; B. Schoenberg ; D. CalnePositron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in lytico-bodig : the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of guam
001070 J. K. C. Tsui ; R. F. Peppard ; K. C. Petruk ; G. Allen ; R. S. Burns ; D. B. CalneDecreased efficay of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants
001072 R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. CalneCortical glucose metabolism in Parkinson's and Alzheimer's disease
001090 M. Guttman ; R. S. Burns ; W. R. W. Martin ; R. F. Peppard ; M. J. Adam ; T. J. Ruth ; G. Allen ; R. A. Parker ; N. B. Tulipan ; D. B. CalnePET studies of Parkinsonian patients treated with autologous adrenal implants
001100 E. C. Wolters ; T. A. Hurwitz ; R. F. Peppard ; D. B. CalneClozapine: an antipsychotic agent in Parkinson's disease?
001104 J. K. C. Tsui ; E. C. Wolters ; R. F. Peppard ; D. B. CalneA double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022